BioAge Labs BIOA
NASDAQ BIOA
$6.61 -0.20 (-2.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioAge Labs (BIOA) Return on Sales [ROS] (2025 - 2026)

Updated

BioAge Labs (BIOA) posted Return on Sales [ROS] of -1196.78% for Q2 2026, down 169.79 percentage points from -1026.99% a year earlier and down 281.37 percentage points from the prior quarter.

Analysis

BioAge Labs (BIOA) Return on Sales [ROS] (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at BioAge Labs was -1026.28%, up 1337.92 percentage points year-over-year; for FY2025, it came in at -1031.46%.

  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -915.40% (Q1 2026), -923.42% (Q4 2025) and -1126.58% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 BioAge Labs 302.59 Mn 302.59 Mn -14.23 Mn -1,196.78%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,196.78%
Mar 31, 2026 -915.40%
Dec 31, 2025 -923.42%
Sep 30, 2025 -1,126.58%
Jun 30, 2025 -1,026.99%
Mar 31, 2025 -1,133.43%
API Access

BioAge Labs Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BIOA&period=max&api_key=YOUR_API_KEY